What is Praxis Precision Medicines Receivables Turnover?
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Praxis Precision Medicines's Revenue for the
three
months ended in Dec. 2024 was $7.46 Mil. Praxis Precision Medicines's average Accounts Receivable for the
three
months ended in Dec. 2024 was $0.00 Mil.
Praxis Precision Medicines Receivables Turnover Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Praxis Precision Medicines's Receivables Turnover
For the Biotechnology subindustry, Praxis Precision Medicines's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Praxis Precision Medicines's Receivables Turnover Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Praxis Precision Medicines's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Praxis Precision Medicines's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Praxis Precision Medicines Receivables Turnover Related Terms
Thank you for viewing the detailed overview of Praxis Precision Medicines's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PRAX has been successfully added to your 